Selecta Biosciences
company
About
Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.
- 51 - 100
Highlights
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $3M
- Industries
- Biopharma,Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 2008
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Their proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles.It was founded in 2008 and is headquartered in Watertown, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$76M
Selecta Biosciences has raised a total of
$76M
in funding over 2 rounds. Their latest funding was raised on
Sep 8, 2015 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 8, 2015 | Series E | $38M | 2 | — | — | Detail |
| Oct 15, 2014 | Private Equity（PE） | $20M | 2 | — | — | Detail |
| Aug 17, 2010 | Grant | $3M | 1 | — | — | Detail |
| Apr 5, 2010 | Series C | $15M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Selecta Biosciences is funded by 3 investors.
Leukon Investments
and Eminent Venture Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Leukon Investments
|
— | Series E |
|
|
— | Series E |
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
